Kapoose Creek Bio is a Canadian biotech company using AI technologies to uncover small molecule medicines from nature with unprecedented speed and scale. Our R&D efforts are supported by off-grid research facilities in the hunt for undiscovered chemistry in environments of unique biodiversity. We have developed a platform – unEarth Rx – that integrates phenotypic screening with advanced machine and deep learning to accelerate the identification of high-quality drug leads and simultaneously determine their mechanism of action. We are building a diversified portfolio of stakes in the next generation of critical medicines, focusing our platform on neuroscience, cancer and infectious disease. Currently our development pipeline is concentrated on compounds with exciting potential in neurological indications.